Literature DB >> 24373949

Cyclic adenosine 3'-5'-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac).

E Vitali1, E Peverelli1, E Giardino1, M Locatelli2, G B Lasio3, P Beck-Peccoz1, A Spada1, A G Lania4, G Mantovani1.   

Abstract

In the pituitary the activation of cyclic adenosine 3'-5'-monophosphate (cAMP) dependent pathways generates proliferative signals in somatotrophs, whereas in pituitary cells of other lineages its effect remains uncertain. Moreover, the specific role of the two main cAMP effectors, protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac), has not been defined. Aim of this study was to investigate the effect of cAMP on pituitary adenomatous cells proliferation and to identify PKA and Epac differential involvement. We found that cAMP increased DNA synthesis and cyclin D1 expression in somatotropinomas, whereas it reduced both parameters in prolactinomas and nonfunctioning adenomas, these effects being replicated in corresponding cell lines. Moreover, the divergent cAMP effects were mimicked by Epac and PKA analogs, which activated Rap1 and CREB, respectively. In conclusion, we demonstrated that cAMP exerted opposite effects on different pituitary cell types proliferation, these effects being mediated by both Epac and PKA.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Exchange proteins directly activated by cAMP (Epac); cAMP; cAMP-dependent protein kinase A (PKA)

Mesh:

Substances:

Year:  2013        PMID: 24373949     DOI: 10.1016/j.mce.2013.12.006

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  13 in total

Review 1.  Protein kinase A defects and cortisol-producing adrenal tumors.

Authors:  Mihail Zilbermint; Constantine A Stratakis
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-06       Impact factor: 3.243

Review 2.  Somatostatin receptor ligands in the treatment of acromegaly.

Authors:  Monica R Gadelha; Luiz Eduardo Wildemberg; Marcello D Bronstein; Federico Gatto; Diego Ferone
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

Review 3.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

4.  Interaction of AIP with protein kinase A (cAMP-dependent protein kinase).

Authors:  Marie Helene Schernthaner-Reiter; Giampaolo Trivellin; Constantine A Stratakis
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

5.  8-Cl-cAMP and PKA I-selective cAMP analogs effectively inhibit undifferentiated thyroid cancer cell growth.

Authors:  Elisa Stellaria Grassi; Alessandra Dicitore; Irene Negri; Maria Orietta Borghi; Giovanni Vitale; Luca Persani
Journal:  Endocrine       Date:  2016-07-27       Impact factor: 3.633

6.  DNA damage and growth hormone hypersecretion in pituitary somatotroph adenomas.

Authors:  Anat Ben-Shlomo; Nan Deng; Evelyn Ding; Masaaki Yamamoto; Adam Mamelak; Vera Chesnokova; Artak Labadzhyan; Shlomo Melmed
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

7.  Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy.

Authors:  Sonali Sinha; Nidhi Dwivedi; Shixin Tao; Abeda Jamadar; Vijayakumar R Kakade; Maura O' Neil; Robert H Weiss; Jonathan Enders; James P Calvet; Sufi M Thomas; Reena Rao
Journal:  Oncogene       Date:  2019-10-15       Impact factor: 9.867

Review 8.  Targeting protein-protein interactions in complexes organized by A kinase anchoring proteins.

Authors:  Ana I Calejo; Kjetil Taskén
Journal:  Front Pharmacol       Date:  2015-09-08       Impact factor: 5.810

9.  Exchange factors directly activated by cAMP mediate melanocortin 4 receptor-induced gene expression.

Authors:  Evi Glas; Harald Mückter; Thomas Gudermann; Andreas Breit
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

10.  Hypoxia and the hypoxia inducible factor 1α activate protein kinase A by repressing RII beta subunit transcription.

Authors:  Kristin Lucia; Yonghe Wu; Jose Monteserin Garcia; Anne Barlier; Michael Buchfelder; Wolfgang Saeger; Ulrich Renner; Günter K Stalla; Marily Theodoropoulou
Journal:  Oncogene       Date:  2020-02-28       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.